NATALIE KHUU: Open Payments
NPI 1447490503 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 68 payments from 15 companies in 2025. Trend: 2023 $445 · 2024 $687 · 2025 $1,462
Food & beverage: $1,296Education: $166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $302 |
| Janssen Biotech, Inc. | 8 | $242 |
| Arcutis Biotherapeutics, Inc. | 10 | $238 |
| Galderma Laboratories, L.P. | 4 | $153 |
| Regeneron Healthcare Solutions, Inc. | 6 | $138 |
| GENZYME CORPORATION | 5 | $103 |
| LEO Pharma Inc. | 4 | $82 |
| Lilly USA, LLC | 2 | $40 |
| UCB, Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Zoryve, NEMLUVIO, ADBRY, Bimzelx, Sotyktu.
Industry payments across NV — which companies pay providers there.
